Stocktoria
Cadre Holdings, Inc. CDRE
NYSE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2021-11-04 · LEI
Cadre Holdings, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $610.3M | $567.6M | $482.5M | $457.8M | $427.3M | $404.6M |
| Gross profit | $259.6M | $233.5M | $200.7M | $175.7M | $170.7M | $152.9M |
| R&D expense | $11.4M | $8.4M | $7.0M | $7.1M | $6.5M | $5.6M |
| SG&A expense | $183.1M | $158.3M | $140.5M | $153.1M | $115.0M | $106.6M |
| Operating income | $67.4M | $66.8M | $56.5M | $16.7M | $51.7M | $49.8M |
| Interest expense | — | — | $4.5M | $6.2M | $16.4M | $24.4M |
| Income tax | $18.2M | $18.1M | $14.3M | $3.6M | $6.5M | -$10.6M |
| Net income | $44.1M | $36.1M | $38.6M | $5.8M | $12.7M | $38.5M |
| EPS (diluted) | $1.02 | $0.90 | $1.02 | $0.16 | $0.44 | $1.40 |
| Operating cash flow | $63.7M | $31.8M | $73.2M | $46.4M | $40.1M | $45.4M |
| Free cash flow | $56.8M | $26.1M | $66.5M | $41.9M | $37.3M | $40.7M |
| Cash & equivalents | $122.9M | $124.9M | — | — | — | — |
| Inventory | $100.3M | $82.4M | $81.0M | $70.3M | $64.0M | $60.9M |
| Total assets | $770.0M | $652.7M | $431.2M | $392.0M | $311.8M | $283.3M |
| Total liabilities | $452.2M | $341.2M | $234.0M | $226.1M | $223.2M | $274.4M |
| Shareholders' equity | $317.8M | $311.5M | $197.2M | $165.9M | $88.6M | $8.9M |
Growth · year-over-year · Revenue CAGR 8.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +7.5% | +17.6% | +5.4% | +7.1% | +5.6% | — |
| Net income growth | +22.2% | -6.5% | +563.9% | -54.0% | -67.1% | — |
| EPS growth | +13.3% | -11.8% | +537.5% | -63.6% | -68.6% | — |
| Free cash flow growth | +117.7% | -60.7% | +58.6% | +12.5% | -8.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.